doi:10.4103/2230-8210.123555 Huber G, Staub JJ, Meier C, et al
doi: 10.3389/fcell.2024.1376639 Received 25 January 2024 Accepted 10 June 2024 Published 02 July 2024 Volume 12 - 2024 Edited by Vandre Casagrande Figueiredo, Oakland University, United States Reviewed by Mengping Wei, Capital Medical University, China Ana Sevilla, University of Barcelona, Spain Updates Copyright 2024 Nussinov, Yavuz, Demirel, Arici, Jang and Tuncbag
Therefore, treatment with Nascobal Nasal Spray should be deferred until symptoms have subsided
GLP-1 receptor agonists typically require patients to be at least 18 years old for weight loss indication, though this varies by specific medication and indication